Genomas Lands $1.4M SBIR Grant | GenomeWeb

NEW YORK (GenomeWeb News) – Genomas has won a $1.4 million grant from the National Institutes of Health to develop pharmacogenomic technology that will help doctors predict drug efficacy and side-effect risk for neuropsychiatric disease patients.

The company plans to use the Small Business Innovation Research grant to continue developing its PhyzioType Systems, which use genetic polymorphisms found through array genotyping and an algorithm to help doctors develop personalized drug prescriptions for antidepressants and antipsychotics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.